SCHEDULE OF ACQUIRED ASSETS IDENTIFIABLE INTANGIBLE ASSETS AND CERTAIN ASSUMED LIABILITIES (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2022	Dec. 31, 2021	Jun. 30, 2021	Dec. 31, 2020
Fair value of assets acquired and (liabilities assumed):
Goodwill	$ 8,079	$ 2,068	$ 2,068	$ 2,068
Kind Therapeutics USA LLC. [Member]
Fair value of consideration transferred:
Cash paid at closing	10,128
Release of escrow	2,444
Severance paid from escrow	556
Less cash acquired	(2,310)
Net cash consideration	10,818
Note payable	5,634
Write-off accounts receivable	658
Write-off of deferred accounts receivable	842
Total fair value of consideration transferred	17,952
Fair value of assets acquired and (liabilities assumed):
Current assets, net of cash acquired	5,047
Property and equipment	622
Goodwill	6,011
Current liabilities	(511)
Total fair value of assets acquired and (liabilities assumed)	17,952
Kind Therapeutics USA LLC. [Member] | Trademarks and Trade Names [Member]
Fair value of assets acquired and (liabilities assumed):
Non-compete agreements	2,041
Kind Therapeutics USA LLC. [Member] | Licenses and Customer Base [Member]
Fair value of assets acquired and (liabilities assumed):
Non-compete agreements	4,700
Kind Therapeutics USA LLC. [Member] | Noncompete Agreements [Member]
Fair value of assets acquired and (liabilities assumed):
Non-compete agreements	$ 42